Evidence map›Paper›PMID 37744461›Full record

ArticleArXiv2023

A Large Open Access Dataset of Brain Metastasis 3D Segmentations with Clinical and Imaging Feature Information.

Divya Ramakrishnan, Leon Jekel, Saahil Chadha, Anastasia Janas, Harrison Moy, Nazanin Maleki, Matthew Sala, Manpreet Kaur, Gabriel Cassinelli Petersen, Sara Merkaj and 12 more

Open access · greenAbstract readPreprint
In one paragraph

Article in ArXiv, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 10 institutions in 3 countries.

Divya RamakrishnanYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Leon JekelYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Saahil ChadhaYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Anastasia JanasYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Harrison MoyYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Nazanin MalekiYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Matthew SalaYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Manpreet KaurYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Gabriel Cassinelli PetersenYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Sara MerkajYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Marc von ReppertYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Ujjwal BaidDivision of Computational Pathology, Department of Pathology & Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Spyridon BakasDivision of Computational Pathology, Department of Pathology & Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Claudia KirschYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Melissa DavisYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Khaled BousabarahVisage Imaging, GmbH, Berlin, Germany.
Wolfgang HollerVisage Imaging, GmbH, Berlin, Germany.
MingDe LinYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Malte WesterhoffVisage Imaging, GmbH, Berlin, Germany.
Sanjay AnejaDepartment of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA.
Fatima MemonYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Mariam S AboianYale School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT, USA.
Yale University · USIndiana University School of MedicineCharité - Universitätsmedizin Berlin · DELeipzig University · DELudwig-Maximilians-Universität München · DEPFH Private University of Applied Sciences · DETulane University · USUniversity of Duisburg-Essen · DEUniversity of Sheffield · GBWesleyan University · US

Funding

Quantitative Multimodal Imaging Biomarkers for Combined Locoregional and Immunotherapy of Liver CancerR01CA206180 · NCI · YALE UNIVERSITY · PI CHAPIRO, JULIUS, DUNCAN, JAMES S · 2016 to 2025
$6.1M
Multi-Center Academic-Industrial Partnership for Personalized Al-Enabled High Count PETR01CA275188 · NCI · YALE UNIVERSITY · PI RAMSEY D. BADAWI, Georges El Fakhri · 2023 to 2026
$2.5M
The Federated Tumor Segmentation (FeTS) platform: An intuitive tool facilitating secure multi-institutional collaborationU01CA242871 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BAKAS, SPYRIDON · 2019 to 2021
$1.1M
NCI NIH HHS R01 CA206180NCI NIH HHS R01 CA275188NCI NIH HHS U01 CA242871
6 · The paper itself

Abstract

Resection and whole brain radiotherapy (WBRT) are the standards of care for the treatment of patients with brain metastases (BM) but are often associated with cognitive side effects. Stereotactic radiosurgery (SRS) involves a more targeted treatment approach and has been shown to avoid the side effects associated with WBRT. However, SRS requires precise identification and delineation of BM. While many AI algorithms have been developed for this purpose, their clinical adoption has been limited due to poor model performance in the clinical setting. Major reasons for non-generalizable algorithms are the limitations in the datasets used for training the AI network. The purpose of this study was to create a large, heterogenous, annotated BM dataset for training and validation of AI models to improve generalizability. We present a BM dataset of 200 patients with pretreatment T1, T1 post-contrast, T2, and FLAIR MR images. The dataset includes contrast-enhancing and necrotic 3D segmentations on T1 post-contrast and whole tumor (including peritumoral edema) 3D segmentations on FLAIR. Our dataset contains 975 contrast-enhancing lesions, many of which are sub centimeter, along with clinical and imaging feature information. We used a streamlined approach to database-building leveraging a PACS-integrated segmentation workflow.

Identifiers

PMID37744461
PMCPMC10516117
OpenAlexW4387002838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.